Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics

@article{Petersen2021MandatoryIA,
  title={Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics},
  author={Eric Petersen and Patricia Schlagenhauf and S. S. Lee and L. Blumberg and Laura D. Kramer and Christina W Obiero and Seif Salem Al-Abri and F. Cunha and Nicola Petrosillo and Antonino di Caro and Phillipe Gautret and S. Shafi and Aisha Abubakar and Tatiana Castro Abreu Pinto and Z. A. Memish and David S C Hui and Alimuddin Zumla and M. P. Grobusch},
  journal={International Journal of Infectious Diseases},
  year={2021},
  volume={108},
  pages={156 - 158}
}
1 Citations
International Journal of Infectious Diseases: from the past quarter-century to the next.
  • P. E, Lee Ss, +8 authors Holmes A
  • Medicine
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
  • 2021

References

SHOWING 1-10 OF 31 REFERENCES
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
TLDR
Only modest differences in vaccine effectiveness were noted with the delta variant as compared with the alpha variant after the receipt of two vaccine doses, which would support efforts to maximize vaccine uptake with two doses among vulnerable populations. Expand
COVID - 19 vaccines under the International Health Regulations — we must use the WHO International Certi fi cate of Vaccination or Prophylaxis
  • Int J Infect Dis
  • 2021
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
TLDR
After 2 doses of either vaccine there were only modest differences in vaccine effectiveness with the B.1. Expand
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
TLDR
Vaccination with either one dose of BNT162b2 or ChAdOx1-S was associated with a significant reduction in symptomatic covid-19 in older adults, and with further protection against severe disease. Expand
Evidence review – public health measures in the aviation sector in the context of COVID-19: quarantine and isolation - 21 May 2021
  • Wkly Epidemiol Rec
  • 2021
Protecting Olympic Participants from Covid-19 - The Urgent Need for a Risk-Management Approach.
TLDR
Protecting Olympic Participants from Covid-19 Plans to protect participants and the public during the Olympics aren’t built on rigorous risk assessment, and fail to consider the ways in which the technology can be abused. Expand
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
TLDR
A single dose of Ad26.COV2.S protected against symptomatic Covid-19 and asymptomatic SARS-CoV-2 infection and was effective against severe–critical disease, including hospitalization and death, in an international, randomized, double-blind, placebo-controlled, phase 3 trial. Expand
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
TLDR
A further prespecified pooled analysis of trials of ChAdOx1 nCoV-19 and exploratory analyses of the impact on immunogenicity and efficacy of extending the interval between priming and booster doses are presented. Expand
...
1
2
3
4
...